We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Horizon Discovery Group Plc | LSE:HZD | London | Ordinary Share | GB00BK8FL363 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 184.50 | 184.50 | 185.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMHZD
RNS Number : 7051V
Horizon Discovery Group plc
26 July 2018
Horizon Discovery Group plc
Block Listing Six Monthly Return and Block Listing Application
26 July 2018
Horizon Discovery Group plc (LSE: HZD) ("Horizon") provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:
Name of applicant: Horizon Discovery Group plc Name of scheme(s): a) Horizon Discovery Limited Enterprise Management Incentive Share Option Scheme b) Horizon Discovery Group plc Long Term Incentive Plan c) Horizon Discovery 2014 Sharesave Scheme d) Horizon Discovery Group plc US Employee Stock Purchase Plan ------------------------------------------ Period of return (from / From: 27 January To: 26 July 2018 to): 2018 -------------------- -------------------- Number of securities originally Total of 3,000,000 ordinary shares admitted and date of admission of 1p each, split: a) 1,398,000 b) 1,392,000 c) 110,000 d) 100,000 Admission date 26 July 2017 ------------------------------------------ Balance of unallotted securities Total of 2,574,510 ordinary shares under schemes from previous of 1p each, split return: a) 1,177,344 b) 1,306,640 c) 24,671 d) 65,855 ------------------------------------------ Plus: The amount by which Total of 500,000 ordinary shares the block scheme(s) has been of 1p each, split increased or application a) 0 has been made to increase b) 150,000 since the date of the last c) 150,000 return (if any increase has d) 200,000 been applied for): As applied for in the below paragraph. ------------------------------------------ Less: Number of securities Total of 498,653 ordinary shares issued/allotted under scheme(s) of 1p each, split during period: a) 398,808 b) 82,951 c) 16,894 d) 0 ------------------------------------------ Equals: Balance under scheme(s) Total of 2,575,857 ordinary shares not yet issued/allotted at of 1p each, split end of period: a) 778,536 b) 1,373,689 c) 157,777 d) 265,855 ------------------------------------------
BLOCK LISTING APPLICATION
Horizon announces that an application has today been made to the London Stock Exchange for the admission of 500,000 Ordinary Shares of 1 pence each (the "Ordinary Shares") in the Company under the Company's existing block listing scheme. These Ordinary Shares will be available to satisfy future exercises of options in accordance with the following employee share plans:
-- Horizon Discovery Group plc Long Term Incentive Plan (up to 150,000 shares) -- Horizon Discovery 2014 Sharesave Scheme (up to 150,000 shares) -- Horizon Discovery Group plc US Employee Stock Purchase Plan (up to 200,000 shares)
It is expected that Admission will occur on 27 July 2018. When issued, these Ordinary Shares will rank pari passu with the existing Ordinary Shares.
ENDS
For further information from Horizon Discovery Group plc, please contact:
Horizon Discovery Group plc
Ian Gilham, Executive Chairman
Terry Pizzie, Chief Executive Officer
Richard Vellacott, Chief Financial Officer
Tel: +44 (0) 1223 655 580
Numis Securities Limited (Broker and NOMAD)
Michael Meade / Freddie Barnfield
Tel: +44 (0) 207 260 1000
Consilium Strategic Communications (Financial Media and Investor Relations)
Mary-Jane Elliott / Matthew Neal / Melissa Gardiner
Tel: +44 (0) 20 3709 5700
Email: horizon@consilium-comms.com
About Horizon Discovery Group plc www.horizondiscovery.com
Horizon Discovery Group plc (LSE: HZD) ("Horizon") is a world leader in gene editing and gene modulation technologies. Horizon designs and engineers cells using its translational genomics platform, a highly precise and flexible suite of DNA editing tools (rAAV, ZFN, CRISPR and Transposon) and, following the acquisition of Dharmacon, Inc., its functional genomics platform comprising gene knockdown (RNAi) and gene expression (cDNA, ORF) tools, for research and clinical applications that advance human health. Horizon's platforms and capabilities enable researchers to alter almost any gene or modulate its function in human or mammalian cell-lines.
Horizon offers an extensive range of catalogue products and related research services to support a greater understanding of the function of genes across all species and the genetic drivers of human disease and the development of personalised molecular, cell and gene therapies. These have been adopted by over 10,000 academic, drug discovery, drug manufacturing and clinical diagnostics customers around the globe, as well as in the Company's own R&D pipeline.
Horizon is headquartered in Cambridge, UK, and is listed on the London Stock Exchange's AIM market under the ticker "HZD".
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BLRFKPDKFBKKOOB
(END) Dow Jones Newswires
July 26, 2018 04:01 ET (08:01 GMT)
1 Year Horizon Discovery Chart |
1 Month Horizon Discovery Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions